Aandeel Novacyt PSE:ALNOV.FR, FR0010397232

quote:

zafira tourer schreef op 10 maart 2020 11:43:

tip

ik hou Visiomed Group al een tijdje in het oog, misschien ook te maken met corona,
de mensen kopen mischien meer medicatie online nu

quote:

Rotel74 schreef op 10 maart 2020 11:47:

[...]
Is het een goed idee om een apart draadje voor Tips/Kanshebbers te maken?
#overzichtelijkheid

quote:

voda schreef op 10 maart 2020 11:49:

[...]
Hebben wij al:

www.iex.nl/Forum/Topic/1368005/2/Waar...

quote:

Rotel74 schreef op 10 maart 2020 11:47:

[...]

Even naar het draadje gaan `Waar beleggen jullie nog meer in` toch?
#overzichtelijkheid

quote:

zafira tourer schreef op 10 maart 2020 12:02:

[...]

staat toch bij dat het maar en tip was

quote:

DeZwarteRidder schreef op 10 maart 2020 12:53:

Primerdesign has already received requests for quotations for 288,000 CE-Mark tests since they were made available to pre-order on 14 February 2020. The Company has received orders for 40,000 RUO tests and requests for quotations for an additional 35,000 RUO tests prior to the launch of the COVID-19 clinical version. Demand for the tests has come from China, the US and the UK, as well as many other countries around the world.

Ze vliegen de tent uit (maar niet heus)....!!!

quote:

DeZwarteRidder schreef op 10 maart 2020 12:53:

Primerdesign has already received requests for quotations for 288,000 CE-Mark tests since they were made available to pre-order on 14 February 2020. The Company has received orders for 40,000 RUO tests and requests for quotations for an additional 35,000 RUO tests prior to the launch of the COVID-19 clinical version. Demand for the tests has come from China, the US and the UK, as well as many other countries around the world.

Ze vliegen de tent uit (maar niet heus)....!!!

quote:

DeZwarteRidder schreef op 10 maart 2020 10:59:

[...]

Launch of CE-IVD Marked

novel coronavirus test

Paris, France and Camberley, UK - 17 February 2020 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to announce that its molecular diagnostics division, Primerdesign, has launched its CE-Mark molecular test for the clinical detection of the novel coronavirus (COVID-19).

The Directors believe that Primerdesign's COVID-19 test is the first CE-Mark test for the 2019 strain of novel coronavirus and follows the Company's rapid launch of its research use only (RUO) coronavirus test on 31 January 2020. As a result of the CE-Mark, the Company's COVID-19 test can be used directly by laboratories and hospitals for the testing of patients without the need for validation by clinicians. The Company anticipates increased demand for its test for COVID-19 due to this extended use for clinical diagnosis.

Primerdesign has already received requests for quotations for 288,000 CE-Mark tests since they were made available to pre-order on 14 February 2020. The Company has received orders for 40,000 RUO tests and requests for quotations for an additional 35,000 RUO tests prior to the launch of the COVID-19 clinical version. Demand for the tests has come from China, the US and the UK, as well as many other countries around the world.

The Company continues to see a high conversion rate from quotations to orders. However, it is difficult to predict how demand for the test will grow as the epidemic is still in its early stages. Since the initial reports of COVID-19, the Company has invested in manufacturing capacity to meet the current and potential future demand for its tests.

The Primerdesign test is being formally evaluated by public health authorities from five countries and the Company is in discussions with these organisations to potentially support their national screening requirements for COVID-19.

As previously announced, the Company has submitted an application to, and remains in discussion with, the US Food and Drug Administration (FDA) for Emergency Use Approval (EUA) of its test for COVID-19, which would allow laboratories in the US to use the test for clinical diagnosis on a temporary basis. The data generated from the CE-Mark approval will be used to support this application.

quote:

Speculatie schreef op 10 maart 2020 13:04:

[...]

Het had je gesierd als je erbij had geschreven, dat dit persbericht was geplaatst op de maandag (17 feb), nadat 3 dagen ervoor (14 feb) de CE-MARK test bekend was gemaakt voor bestellingen!

Je commentaar is wederom zeer kwalijk.

quote:

MrSV schreef op 10 maart 2020 13:12:

[...]

Beste ZwarteRidder, ik snap niet vanwaar je het haalt dat Novacyt hun test niet mag gebruiken bij mensen. begrijp je nu wat er staat in bovenstaand bericht? Begrijp je dat ze deze test wel mogen gebruiken bij mensen? Leg bovenstaande tekst anders eens met je eigen woorden uit zodat we weten dat je het snapt...